Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNASDAQ:OPCHNASDAQ:RDNTNYSE:TDOC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$43.49+2.4%$44.65$15.81▼$50.89$5.37B1.52.16 million shs1.29 million shsOPCHOption Care Health$34.79-0.5%$32.69$21.39▼$35.53$5.71B1.331.71 million shs1.26 million shsRDNTRadNet$52.51+3.7%$57.16$45.82▼$93.65$3.89B1.85634,966 shs847,983 shsTDOCTeladoc Health$7.80+0.5%$10.29$6.76▼$15.21$1.35B1.276.19 million shs5.01 million shsElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health-0.31%-8.59%-0.19%+39.02%+109.73%OPCHOption Care Health0.00%-0.65%+4.33%+50.65%+6.59%RDNTRadNet+1.81%-0.16%-8.74%-27.52%+5.22%TDOCTeladoc Health-2.60%-10.21%-18.76%-14.55%-47.70%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health4.2729 of 5 stars3.52.00.04.43.32.50.6OPCHOption Care Health3.9296 of 5 stars2.43.00.04.23.72.50.6RDNTRadNet3.9686 of 5 stars3.71.00.04.62.82.50.0TDOCTeladoc Health3.064 of 5 stars4.22.00.00.01.12.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.00Buy$48.9512.55% UpsideOPCHOption Care Health 2.75Moderate Buy$33.00-5.15% DownsideRDNTRadNet 3.40Buy$73.2539.50% UpsideTDOCTeladoc Health 2.39Hold$11.2644.42% UpsideCurrent Analyst Ratings BreakdownLatest TDOC, OPCH, GH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/26/2025GHGuardant HealthStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$55.00 ➝ $55.003/24/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$74.00 ➝ $60.003/6/2025GHGuardant HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.003/6/2025OPCHOption Care HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$40.00 ➝ $41.003/5/2025RDNTRadNetRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Strong-Buy$85.00 ➝ $65.003/3/2025TDOCTeladoc HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $13.002/27/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$33.00 ➝ $38.002/27/2025TDOCTeladoc HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$13.00 ➝ $12.002/27/2025TDOCTeladoc HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold2/26/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$34.00 ➝ $50.002/24/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$47.00 ➝ $52.00(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M7.26N/AN/A$1.34 per share32.46OPCHOption Care Health$5.00B1.14$2.02 per share17.19$8.03 per share4.33RDNTRadNet$1.83B2.12$2.79 per share18.81$11.79 per share4.45TDOCTeladoc Health$2.57B0.53$0.50 per share15.64$14.05 per share0.56Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%5/8/2025 (Estimated)OPCHOption Care Health$267.09M$1.2229.2427.612.304.37%15.30%6.57%4/29/2025 (Estimated)RDNTRadNet$3.04M$0.03N/A99.08N/A-0.25%4.29%1.45%5/6/2025 (Estimated)TDOCTeladoc Health-$220.37M-$5.88N/AN/AN/A-37.91%-10.06%-4.86%4/24/2025 (Estimated)Latest TDOC, OPCH, GH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/29/2025N/AOPCHOption Care Health$0.36N/AN/AN/A$1.26 billionN/A4/24/2025N/ATDOCTeladoc Health-$0.32N/AN/AN/A$619.38 millionN/A2/27/2025Q4 2024RDNTRadNet$0.21$0.22+$0.01$0.07$459.42 million$477.10 million2/26/2025Q4 2024TDOCTeladoc Health-$0.21-$0.28-$0.07-$0.28$639.44 million$640.49 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ATDOCTeladoc HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A6.225.85OPCHOption Care Health0.771.731.32RDNTRadNet0.892.162.16TDOCTeladoc Health0.661.731.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%OPCHOption Care Health98.05%RDNTRadNet77.90%TDOCTeladoc Health76.82%Insider OwnershipCompanyInsider OwnershipGHGuardant Health5.50%OPCHOption Care Health0.64%RDNTRadNet5.12%TDOCTeladoc Health0.95%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,790123.42 million116.76 millionNot OptionableOPCHOption Care Health5,600164.24 million169.09 millionOptionableRDNTRadNet8,97074.04 million70.24 millionOptionableTDOCTeladoc Health5,100173.67 million170.53 millionOptionableTDOC, OPCH, GH, and RDNT HeadlinesRecent News About These CompaniesTeladoc Health (NYSE:TDOC) Expands Connected Care Partnerships Amid US Tariff ConcernsApril 2 at 5:48 PM | finance.yahoo.comShould Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?March 30 at 9:30 AM | fool.comWhy Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?March 28, 2025 | zacks.comTeladoc Health, Inc. (TDOC) Stock ForecastsMarch 27, 2025 | ca.finance.yahoo.comTeladoc's Meltdown May Not Be Over Yet - Minimal Growth OpportunitiesMarch 26, 2025 | seekingalpha.comTeladoc (TDOC) Flat As Market Sinks: What You Should KnowMarch 26, 2025 | zacks.comTeladoc Health Inc.March 24, 2025 | wsj.com56,131 Shares in Teladoc Health, Inc. (NYSE:TDOC) Bought by Proficio Capital Partners LLCMarch 24, 2025 | marketbeat.comVinva Investment Management Ltd Takes Position in Teladoc Health, Inc. (NYSE:TDOC)March 23, 2025 | marketbeat.comInsider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 11,011 Shares of StockMarch 22, 2025 | marketbeat.comAdam C. Vandervoort Sells 11,011 Shares of Teladoc Health, Inc. (NYSE:TDOC) StockMarch 22, 2025 | insidertrades.comTeladoc (TDOC) Exceeds Market Returns: Some Facts to ConsiderMarch 19, 2025 | zacks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOCMarch 19, 2025 | accessnewswire.comCharles Schwab Investment Management Inc. Increases Holdings in Teladoc Health, Inc. (NYSE:TDOC)March 19, 2025 | marketbeat.comTeladoc Health, Inc. (NYSE:TDOC) Shares Sold by Bank of New York Mellon CorpMarch 18, 2025 | marketbeat.comTeladoc Health, Inc. (NYSE:TDOC) Given Average Rating of "Hold" by BrokeragesMarch 18, 2025 | marketbeat.comTeladoc Health Q1 Preview: Analyst Says Strategic Direction Is Good, But There's 'More Work To Be Done'March 17, 2025 | benzinga.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOCMarch 17, 2025 | prnewswire.comJ.P. Morgan Keeps Their Hold Rating on Teladoc (TDOC)March 17, 2025 | markets.businessinsider.comDoes Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy?March 17, 2025 | fool.comZacks Research Reduces Earnings Estimates for Teladoc HealthMarch 17, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?Archer Aviation Stock Climbs as Midnight eVTOL Nears RealityBy Jeffrey Neal Johnson | March 10, 2025View Archer Aviation Stock Climbs as Midnight eVTOL Nears RealityNVIDIA Stock Remains Stunningly Undervalued—Here’s WhyBy Thomas Hughes | March 11, 2025View NVIDIA Stock Remains Stunningly Undervalued—Here’s WhyJoby Aviation: From Prototype to ProfitabilityBy Jeffrey Neal Johnson | March 11, 2025View Joby Aviation: From Prototype to ProfitabilityWord-of-Mouth Winners: 2 Stocks Growing Without Big Ad BudgetsBy Leo Miller | March 21, 2025View Word-of-Mouth Winners: 2 Stocks Growing Without Big Ad BudgetsTDOC, OPCH, GH, and RDNT Company DescriptionsGuardant Health NASDAQ:GH$43.49 +1.02 (+2.40%) Closing price 04:00 PM EasternExtended Trading$41.08 -2.41 (-5.54%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$34.79 -0.16 (-0.46%) Closing price 04:00 PM EasternExtended Trading$34.54 -0.24 (-0.70%) As of 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.RadNet NASDAQ:RDNT$52.51 +1.89 (+3.73%) Closing price 04:00 PM EasternExtended Trading$49.76 -2.76 (-5.25%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Teladoc Health NYSE:TDOC$7.80 +0.04 (+0.52%) Closing price 03:58 PM EasternExtended Trading$7.40 -0.40 (-5.13%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analyst Targets Signal More Growth in CrowdStrike Stock NextEra Energy Stock Sees Spike in Bullish Call Activity 2 Reasons to Buy Apple Stock and 1 Significant Risk Salesforce: The Most Resilient Software Stock for Downturns D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy Boeing Stock Upgraded After Beating Lockheed for Jet Deal Amazon Falls Back to a Key Support Line: Here's How to Play It Why Howmet Could Be the Sleeper Aerospace Name of 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
